Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Jan 2026 for Regeneron Pharmaceuticals, INC.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
N. Anthony Coles: trading record in brief
N. Anthony Coles is a declared insider at 2 companies (board member); the most frequent names are Cerevel Therapeutics Holdings, Inc. and Regeneron Pharmaceuticals, Inc. We count 32 filings; the first trade dates from 13 August 2021 and the latest from 2 January 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 6 January 2026, the filings show a share grant in Regeneron Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to N. Anthony Coles
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations32 total
155 shares0Common StockSEC:0001197018-26-000002:0
166 shares0Common StockSEC:0001968202-25-000010:0
15,638 sharesCommon StockSEC:0000950170-24-090789:0
25,000 shares@ US$3.502.9% of flowCommon StockSEC:0000950170-24-081490:0
10,290 sharesCommon StockSEC:0000950170-24-070736:0
50,000 shares@ US$3.505.7% of flowCommon StockSEC:0000950170-24-069284:0
50,000 shares@ US$3.505.8% of flowCommon StockSEC:0000950170-24-059788:0
50,000 shares@ US$3.505.8% of flowCommon StockSEC:0000950170-24-041073:0
50,000 shares@ US$3.505.8% of flowCommon StockSEC:0000950170-24-027156:0
50,000 shares@ US$3.505.8% of flowCommon StockSEC:0000950170-24-025036:0
15,440 sharesCommon StockSEC:0000950170-24-012953:0
135 shares0Common StockSEC:0001968202-24-000029:0
50,000 shares@ US$3.505.7% of flowCommon StockSEC:0000950170-24-001864:0
22,824 shares@ US$3.502.7% of flowCommon StockSEC:0000950170-23-064517:0
27,076 shares@ US$3.503.2% of flowCommon StockSEC:0000950170-23-062217:0
38,599 shares@ US$3.504.6% of flowCommon StockSEC:0000950170-23-059520:0
50,000 shares@ US$3.505.9% of flowCommon StockSEC:0000950170-23-047297:0
50,000 shares@ US$3.505.7% of flowCommon StockSEC:0000950170-23-032878:0
50,000 shares@ US$3.505.8% of flowCommon StockSEC:0000950170-23-026502:0
50,000 shares@ US$3.505.7% of flowCommon StockSEC:0000899243-23-012418:0
50,000 shares@ US$3.505.7% of flowCommon StockSEC:0000950170-23-012731:0
47,000 shares@ US$3.505.5% of flowCommon StockSEC:0000899243-23-007176:0
50,000 shares@ US$3.505.8% of flowCommon StockSEC:0000899243-23-004360:0
50,000 shares@ US$3.505.9% of flowCommon StockSEC:0000899243-23-001184:0
165 shares0Common StockSEC:0001883850-23-000012:0
25 of 32 declarations
